Skip to main content
Earnings Labs
NewAmsterdam Pharma Company N.V. logo

NewAmsterdam Pharma Company N.V. (NAMS) Earnings

NASDAQ·Healthcare·Biotechnology

$20.62

+0.56%

Mkt Cap $2.30B

EPS — Estimate vs Actual

Mkt Cap

$2.30B

P/E

—

Fwd P/E

—

P/S

102.11

Rev TTM

—

EPS TTM

-$1.81